IVVD Q4 2022 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$48M

Net Income

-$45M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$49M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$383M

Total Liabilities

$27M

Stockholders' Equity

$356M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$48M	-$83M	+42.0%
Net Income	-$45M	-$83M	+46.3%